The pharmaceutical sector continues to transform under the influence of Artificial Intelligence (AI) and Big Data, which promise to revolutionize current practices and optimize services. Initiatives such as those by MeSoigner, which uses AI to lighten the load of pharmacists, illustrate this trend. However, this technological transition raises crucial questions about the implications for SMEs and micro-enterprises, particularly in terms of costs, training, and regulatory compliance. Recent incidents related to AI, notably those involving OpenAI, also highlight the ethical and security challenges associated with these technologies.
Débloquez l'Analyse Complète
Accédez instantanément à nos insights exclusifs générés par IA, basés sur l'agrégation de centaines de sources sectorielles.
